HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D

No abstract is available for this paper.

• Publication year

  2003

• Venue

  AIDS (London)

• Publication date

  2003-03-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00002030-200303070-00006PMID 12598771
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin-D

  2020cited by this paper
• Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir.

  2003cited by this paper
• Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir

  2001cited by this paper
• Induction of CYP3A4 by 1 alpha,25-dihydroxyvitamin D3 is human cell line-specific and is unlikely to involve pregnane X receptor.

  2001cited by this paper
• Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy

  2001cited by this paper
• Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads.

  2000cited by this paper
• Identification of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression in macrophages.

  2000cited by this paper
• Insulin resistance in HIV protease inhibitor-associated diabetes.

  1999cited by this paper
• Equilibrium distribution of HIV antiviral drugs into human peripheral blood mononuclear cells (PBMC) is controlled by free drug concentration in the extracellular medium.

  1999cited by this paper
• Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

  1999cited by this paper
• Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study.

  1999cited by this paper
• Severe premature coronary artery disease with protease inhibitors.

  1998cited by this paper
• Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with Ritonavir

  1998cited by this paper
• Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir.

  1998cited by this paper
• "Buffalo hump" in men with HIV-1 infection.

  1998cited by this paper
• A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

  1998cited by this paper
• Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway

  1998cited by this paper
• Abnormal fat distribution and use of protease inhibitors.

  1998cited by this paper
• Abnormal fat distribution and use of protease inhibitors

  1998cited by this paper
• HIV-1 protease inhibitors.

  1997cited by this paper
• HIV-1 protease inhibitors. A review for clinicians.

  1997cited by this paper
• Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3.

  1997cited by this paper
• [Inhibition of steroidogenesis by ketoconazole. Therapeutic uses].

  1997cited by this paper
• New-onset diabetes mellitus associated with use of protease inhibitor.

  1997cited by this paper
• Severe Diabetes Associated with Protease Inhibitor Therapy

  1997cited by this paper
• HIV-1 protease inhibitors. A review for clinicians.

  1997cited by this paper
• Bone Mineral Density in Patients with Human Immunodeficiency Virus Infection

  1997cited by this paper
• Vitamin D and bone health.

  1996cited by this paper
• 1,25-Dihydroxyvitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexamethasone depending on the vitamin D receptor level in cultured human osteoblasts.

  1996cited by this paper
• Genomic actions of 1,25-dihydroxyvitamin D3.

  1995cited by this paper
• Extrarenal production of calcitriol.

  1994cited by this paper
• Extrarenal production of calcitriol in normal and uremic humans.

  1991cited by this paper
• Metabolism of a cyclopropane-ring-containing analog of 1 alpha-hydroxyvitamin D3 in a hepatocyte cell model. Identification of 24-oxidized metabolites.

  1990influential reference
• Extrarenal production of calcitriol.

  1990cited by this paper
• Ketoconazole-induced reduction in serum 1,25-dihydroxyvitamin D and total serum calcium in hypercalcemic patients.

  1988cited by this paper
• Ketoconazole-induced stimulation of gonadotropin output in men: basis for a potential test of gonadotropin reserve.

  1986cited by this paper
• Ketoconazole-induced reduction in serum 1,25-dihydroxyvitamin D.

  1986cited by this paper
• FAST TRACK: A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome

  year unknowncited by this paper
• ␥-interferon-induced Resistance to 1,25-(oh) 2 D 3 in Human Monocytes and Macrophages: a Mechanism for the Hypercalcemia of Various Granulomatoses*

  year unknowncited by this paper

• Vitamin D Status in People Living with HIV: Assessment of 25(OH)D Levels and Associated Factors—A Cross-Sectional Study

  2026cites this paper
• Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical Trial

  2025cites this paper
• Vitamin D in Melanoma: Potential Role of Cytochrome P450 Enzymes

  2024cites this paper
• Breaking Down Bone Disease in People Living with HIV: Pathophysiology, Diagnosis, and Treatment.

  2024cites this paper
• Unilateral avascular necrosis of the right hip in an HIV patient with tearing of the rectus femoris and adductor longus muscles

  2024cites this paper
• Assessment of Some Micronutrients and Vitamins of HIV Positive Patients in South-South Nigeria

  2024cites this paper
• Pharmacokinetics of vitamin dosage forms: A complete overview

  2023cites this paper
• A Systematic Review and Meta-Analysis of Randomized Controlled Trials of the Effects of Vitamin D Supplementation on Children and Young Adults with HIV Infection.

  2022cites this paper
• A Study of Vitamin D Levels in HIV Seropositive Patients

  2022cites this paper
• High prevalence of vitamin D deficiency in HIV-infected individuals in comparison with the general population across Punjab province, Pakistan

  2022cites this paper
• Cholecalciferol Supplementation Does Not Affect the Risk of HIV Progression, Viral Suppression, Comorbidities, Weight Loss, and Depression Among Tanzanian Adults Initiating Antiretroviral Therapy: Secondary Outcomes of a Randomized Trial.

  2022cites this paper
• Human immunodeficiency virus influence bone tissue

  2022cites this paper
• Sirtuins as Interesting Players in the Course of HIV Infection and Comorbidities

  2021cites this paper
• Human immunodeficiency virus and osteoporosis

  2021cites this paper
• Vitamin D status and associated factors among HIV-infected children and adolescents on antiretroviral therapy in Kampala, Uganda

  2021cites this paper
• Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn’s Disease: A Pilot Study

  2021cites this paper
• Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz

  2021cites this paper
• A Literature Review of the Potential Impact of Medication on Vitamin D Status

  2021cites this paper
• HIV Infection, HIV Therapy, and Bone Health

  2020cites this paper
• Risk Factors of Hypovitaminosis D in HIV-Infected Patients on Suppressive Antiretroviral Therapy

  2020cites this paper
• Vitamin D Status Modulates Inflammatory Response in HIV+ Subjects: Evidence for Involvement of Autophagy and TG2 Expression in PBMC

  2020cites this paper
• Prophylaxis of Pain and Fractures within Feet in the Course of Osteoporosis: The Issue of Diagnosing

  2020cites this paper
• People living with HIV and fracture risk

  2020cites this paper
• Assessing changes in vitamin D over 48 weeks in treatment-naïve HIV individuals starting lopinavir/ritonavir monotherapy.

  2020cites this paper
• Predictive Factors of Vitamin D Inadequacy among Older Adults in the United States.

  2019cites this paper
• Serum Vitamin D is Differentially Associated with Socioemotional Adjustment in Early School-Aged Ugandan Children According to Perinatal HIV Status and In Utero/Peripartum Antiretroviral Exposure History

  2019cites this paper
• VDR polymorphisms influence immunological response in HIV-1+ individuals undergoing antiretroviral therapy

  2019cites this paper
• DIAGNOSIS OF ENDOCRINE DISEASE: Drug-induced endocrinopathies and diabetes: a combo-endocrinology overview.

  2019cites this paper
• Low Vitamin D is associated with Coronary Atherosclerosis in Women with HIV

  2019cites this paper
• Fracture Risk Assessment in People Living with HIV Infection

  2019cites this paper
• The Hidden Burden of Fractures in People Living With HIV

  2018cites this paper
• Continued Interest and Controversy: Vitamin D in HIV

  2018cites this paper
• Human Immunodeficiency Virus and Bone

  2018cites this paper
• The impact of vitamin D supplementation on musculoskeletal health outcomes in children, adolescents, and young adults living with HIV: A systematic review

  2018cites this paper
• Osteomalazie – Klinik, Diagnostik und Therapie

  2018cites this paper
• Prevalence of low bone mass and changes in vitamin D levels in human immunodeficiency virus-infected adults unexposed to antiretrovirals.

  2018cites this paper
• Human cytochrome P450 enzymes 5–51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition – toxic effects and benefits

  2018cites this paper
• Vitamin D and Infectious Diseases

  2018cites this paper
• Vitamin D supplementation, bone turnover, and inflammation in HIV-infected patients.

  2018cites this paper
• IL RUOLO DEL PATHWAY SOCS-1/TRAF-6 NELL'INCREMENTO DELL'OSTEOCLASTOGENESI IN PAZIENTI HIV+ IN CART

  2018cites this paper
• Morphological analysis of the skeletal development in lateral cephalometric radiographs of HIV infected children ongoing Highly Active Antiretroviral Therapy

  2018cites this paper
• Evaluación de la afectación ósea en el paciente infectado por el virus de la inmunodeficiencia humana

  2017cites this paper
• Vitamin D Status in Children Living with HIV on Highly Active Antiretroviral Therapy

  2017cites this paper
• Immunopotentiation in the Presence of Tenofovir-induced Phosphaturia in HIV-infected Patients on Tenofovir

  2017cites this paper
• Full title : Reduced bone mineral density in HIV-infected patients : prevalence and associated factors , ANRS CO 3 Aquitaine cohort Short title : Reduced bone mineral density in HIV patients

  2017cites this paper
• Association between Vitamin D Status, Oxidative Stress Biomarkers and Viral Load in Human Immunodeficiency Virus Type 1 Infection.

  2017cites this paper
• Effects of cholecalciferol supplementation on serum and urinary vitamin D metabolites and binding protein in HIV-infected youth.

  2017cites this paper
• Bone Loss in HIV Infection

  2017cites this paper
• Drug‐Mediated Gene Regulation of Vitamin D3 Metabolism in Primary Human Dermal Fibroblasts

  2017cites this paper
• Vitamin D deficiency in ART-naïve patients 2

  2017cites this paper
• Motor neuron-like NSC-34 cells as a new model for the study of vitamin D metabolism in the brain.

  2016cites this paper
• Effects of Osteoporosis‐Inducing Drugs on Vitamin D‐Related Gene Transcription and Mineralization in MG‐63 and Saos‐2 Cells

  2016cites this paper
• Vitamin D and bone loss in HIV

  2016cites this paper
• Hypovitaminosis D and hyperparathyroidism: effects on bone turnover and bone mineral density among perinatally HIV-infected adolescents

  2016cites this paper
• The protease inhibitors and HIV-associated bone loss

  2016cites this paper
• Effects of Antiretroviral Molecules on Survival and Gene Expression of An Osteoblast-like Cell Line.

  2016cites this paper
• An oral high dose of cholecalciferol restores vitamin D status in deficient postmenopausal HIV-1-infected women independently of protease inhibitors therapy: a pilot study

  2016cites this paper
• Efavirenz is associated with higher bone mass in South African children with HIV

  2016cites this paper
• Alteraciones endocrinometabólicas en pacientes ambulatorios con infección por virus de la inmunodeficiencia humana

  2016cites this paper
• Seminarios de la Fundación Española de Reumatología

  2016cites this paper
• Vitamin D status in a Brazilian cohort of adolescents and young adults with perinatally acquired human immunodeficiency virus infection

  2016cites this paper
• Vitamin D Deficiency and Metabolism in HIV-Infected and HIV-Uninfected Men in the Multicenter AIDS Cohort Study

  2016cites this paper
• Seminarios de la Fundación Española de Reumatología

  2016cites this paper
• Success of Standard Dose Vitamin D Supplementation in Treated Human Immunodeficiency Virus Infection

  2015cites this paper
• Vitamin D Deficiency is Common in HIV-Infected Southern Australian Adults

  2015cites this paper
• Micronutrients in HIV Infection Without HAART

  2015cites this paper
• Insuficiência de vitamina D em pacientes infectados pelo HIV tratados com terapia antirretroviral contendo tenofovir

  2015cites this paper
• Vitamin D and HIV Infection

  2015cites this paper
• Vitamin D supplementation regimens for HIV- infected patients : a historical chart review

  2015cites this paper
• Effects on Vitamin D, Bone and the Kidney of Switching from Fixed-Dose Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz to Darunavir/ Ritonavir Monotherapy: A Randomized, Controlled Trial (MIDAS)

  2015cites this paper
• Vitamin D Deficiency and Immune Function in African American, HIV-Infected Men

  2015cites this paper
• Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.

  2015cites this paper
• Vitamin D supplementation and antibacterial immune responses in adolescents and young adults with HIV/AIDS.

  2015cites this paper
• Vitamin D and HIV Infection: A Systematic Review

  2015cites this paper
• Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study.

  2015cites this paper
• High-dose Vitamin D3 Supplementation in Children and Young Adults with HIV: A Randomized, Placebo-controlled Trial

  2015cites this paper
• High frequency of deficient consumption and low blood levels of 25-hydroxyvitamin D in HIV-1-infected adults from São Paulo city, Brazil

  2015cites this paper
• Ultraviolet Index and Location are Important Determinants of Vitamin D Status in People with Human Immunodeficiency Virus

  2015cites this paper
• Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy

  2015cites this paper
• Heterogeneity in Nutritional and Lipid Profiles in Children and Adolescents with Human Immunodeficiency Virus Treated with Highly Active Antiretroviral Therapy

  2015cites this paper
• HIV/AIDS and Bone Health: The Role of Nutrition

  2015cites this paper
• Low vitamin D status among pregnant Latin American and Caribbean women with HIV Infection

  2015cites this paper
• The Role of Vitamin D in Human Immunodeficiency Virus Infection

  2015cites this paper
• Relationship between Vitamin D Nutritional Status and Human Immunodeficiency Virus Infection

  2015cites this paper
• Long-term changes in bone mineral density after switching to a protease inhibitor monotherapy in HIV-infected subject.

  2015cites this paper
• Vitamin D Insufficiency/Deficiency in HIV-Infected Inner City Youth

  2014cites this paper
• Anti-Inflammatory and Antimicrobial Actions of Vitamin D in Combating TB/HIV

  2014cites this paper
• Determination of optimal vitamin D3 dosing regimens in HIV-infected paediatric patients using a population pharmacokinetic approach.

  2014cites this paper
• Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients.

  2014cites this paper
• Vitamin D and calcium abnormalities in the HIV-infected population.

  2014cites this paper
• Vitamin D deficiency in HIV: a shadow on long-term management?

  2014cites this paper
• Vitamin-D pathway genes and HIV-1 disease progression in injection drug users.

  2014cites this paper
• Editorial: Metabolic Bone Disease in Human Immunodeficiency Virus-Infected Children

  2014cites this paper
• Vitamin D status of human immunodeficiency virus–positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: Multi‐site study

  2014cites this paper
• Prevalence of vitamin D deficiency in HIV-positive, antiretroviral treatment-naïve patients in a single centre study

  2014cites this paper
• [High frequency of hypovitaminosis D and low bone mineral density in a sample of HIV-infected men in Chile].

  2014cites this paper
• Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection.

  2014cites this paper
• Bone Alterations Associated with HIV

  2014cites this paper
• Metabolic complications and treatment of perinatally HIV-infected children and adolescents

  2013cites this paper
• LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals.

  2013influential citation